Brain+ ApS (BRAINP) - Total Assets
Based on the latest financial reports, Brain+ ApS (BRAINP) holds total assets worth Dkr35.35 Million DKK (≈ $5.53 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Brain+ ApS (BRAINP) shareholders funds for net asset value and shareholders' equity analysis.
Brain+ ApS - Total Assets Trend (2015–2024)
This chart illustrates how Brain+ ApS's total assets have evolved over time, based on quarterly financial data.
Brain+ ApS - Asset Composition Analysis
Current Asset Composition (December 2024)
Brain+ ApS's total assets of Dkr35.35 Million consist of 2.5% current assets and 97.5% non-current assets.
| Asset Category | Amount (DKK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Dkr0.00 | 0.2% |
| Accounts Receivable | Dkr707.52K | 2.1% |
| Inventory | Dkr0.00 | 0.0% |
| Property, Plant & Equipment | Dkr0.00 | 0.0% |
| Intangible Assets | Dkr32.22 Million | 97.2% |
| Goodwill | Dkr0.00 | 0.0% |
Asset Composition Trend (2015–2024)
This chart illustrates how Brain+ ApS's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Brain+ ApS market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Brain+ ApS's current assets represent 2.5% of total assets in 2024, a decrease from 21.0% in 2015.
- Cash Position: Cash and equivalents constituted 0.2% of total assets in 2024, down from 4.8% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 97.0% of total assets, an increase from 78.0% in 2015.
- Asset Diversification: The largest asset category is intangible assets at 97.2% of total assets.
Brain+ ApS Competitors by Total Assets
Key competitors of Brain+ ApS based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Alcidion Group Ltd
AU:ALC
|
Australia | AU$115.63 Million |
|
DocCheck AG
XETRA:AJ91
|
Germany | €53.98 Million |
|
TRELLUS HEALTH LS -0006
F:85Q
|
Germany | €9.22 Million |
|
Pro Medicus Ltd
AU:PME
|
Australia | AU$533.91 Million |
|
Echoiq Ltd
AU:EIQ
|
Australia | AU$17.99 Million |
|
ARTRYA Ltd
AU:AYA
|
Australia | AU$23.68 Million |
|
Cogstate Ltd
AU:CGS
|
Australia | AU$64.77 Million |
|
Oneview Healthcare Plc
AU:ONE
|
Australia | AU$15.49 Million |
Brain+ ApS - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.80 | 1.40 | 0.25 |
| Quick Ratio | 1.80 | 1.40 | 0.25 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Dkr2.26 Million | Dkr1.79 Million | Dkr-19.24 Million |
Brain+ ApS - Advanced Valuation Insights
This section examines the relationship between Brain+ ApS's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.28 |
| Latest Market Cap to Assets Ratio | 0.02 |
| Asset Growth Rate (YoY) | -7.9% |
| Total Assets | Dkr33.13 Million |
| Market Capitalization | $744.48K USD |
Valuation Analysis
Below Book Valuation: The market values Brain+ ApS's assets below their book value (0.02x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Brain+ ApS's assets decreased by 7.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Brain+ ApS (2015–2024)
The table below shows the annual total assets of Brain+ ApS from 2015 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | Dkr33.13 Million ≈ $5.18 Million |
-7.88% |
| 2023-12-31 | Dkr35.97 Million ≈ $5.63 Million |
-20.72% |
| 2022-12-31 | Dkr45.37 Million ≈ $7.10 Million |
-3.22% |
| 2021-12-31 | Dkr46.88 Million ≈ $7.34 Million |
+56.86% |
| 2020-12-31 | Dkr29.89 Million ≈ $4.68 Million |
+25.53% |
| 2019-12-31 | Dkr23.81 Million ≈ $3.73 Million |
+4.57% |
| 2018-12-31 | Dkr22.77 Million ≈ $3.56 Million |
+40.14% |
| 2017-12-31 | Dkr16.25 Million ≈ $2.54 Million |
+45.76% |
| 2016-12-31 | Dkr11.15 Million ≈ $1.74 Million |
+22.25% |
| 2015-12-31 | Dkr9.12 Million ≈ $1.43 Million |
-- |
About Brain+ ApS
Brain+ A/S, a healthtech company, develops and commercializes technology solutions in dementia care primarily for cognitive stimulation therapy. The company is developing Ayla, a scalable dementia care platform that offers practical, human-centered, and clinically proven software-based dementia therapy and care solutions. It is also developing Ayla " your CST Assistant, a software-based dementia … Read more